We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Stockbroker tips from ShareCast

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Broker tips: AstraZeneca, Morgan Sindall

Fri 13 February 2026 14:11

(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.

Shore Capital lowers AstraZeneca to 'hold'

Fri 13 February 2026 13:59

(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.

Berenberg hikes target price on Morgan Sindall

Fri 13 February 2026 09:26

(Sharecast News) - Analysts at Berenberg hiked their target price on construction firm Morgan Sindall from 5,400p to 5,800p on Friday in order to reflect another strong performance from the group's fit out division.

Broker tips: Unite, Drax, Dunelm, Barratt Redrow, Schroders

Thu 12 February 2026 14:21

(Sharecast News) - JPMorgan reinstated coverage of Unite Group on Thursday at 'overweight' with a 725p price target as it said the stock's recent de-rating was excessive given structural drivers.

JPMorgan reinstates coverage of Unite Group at 'overweight'

Thu 12 February 2026 13:54

(Sharecast News) - JPMorgan reinstated coverage of Unite Group on Thursday at 'overweight' with a 725p price target as it said the de-rating was excessive given structural drivers.

Citi downgrades Drax to 'neutral' from 'buy'

Thu 12 February 2026 13:10

(Sharecast News) - Citi downgraded Drax on Thursday to 'neutral' from 'buy' as it said the shares were already discounting much of the probability-weighted upside, but lifted the price target to 923p from 850p.

Canaccord Genuity hails growth potential at Dunelm, keeps 'buy' rating

Thu 12 February 2026 11:38

(Sharecast News) - Canaccord Genuity has reiterated its 'buy' rating for Dunelm following the homeware retailer's interim results this week, highlighting the company's long-term potential and strategic direction led by its new chief executive.

Nuveen's price for Schroders 'too cheap', says Panmure Liberum

Thu 12 February 2026 11:08

(Sharecast News) - Panmure Liberum said on Thursday that US investment manager Nuveen's 612p a share takeover offer for Schroders is "too cheap" and "only a touch ahead of where we might have been pitching a new target price in an independent world".

RBC Capital Markets lowers target price on Barratt Redrow

Thu 12 February 2026 08:38

(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on property developer Barratt Redrow from 450p to 425p on Thursday as it updated its estimates to account for the firm's interim results.

Broker tips: Flowtech Fluidpower, Mony Group, Future, EasyJet

Wed 11 February 2026 14:00

(Sharecast News) - Canaccord Genuity lowered its target price on industrial supplies firm Flowtech Fluidpower from 130p to 100p on Wednesday, even as it said the group was "unlocking European growth".